@article{ref1,
title="The cost of borderline personality disorder: societal cost of illness in BPD-patients",
journal="European psychiatry",
year="2007",
author="van Asselt, A. D. I. and Dirksen, C. D. and Arntz, Arnoud and Severens, J. L.",
volume="22",
number="6",
pages="354-361",
abstract="BACKGROUND: Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed. OBJECTIVE: Estimate the societal cost of BPD in the Netherlands. STUDY DESIGN: We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty. PATIENTS: All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5 years and 92% was female. RESULTS: Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was 2,222,763,789 euros (1,372,412,403-3,260,248,300 euros), only 22% was healthcare-related. Costs per patient were 16,852 euros. CONCLUSIONS: Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.<p /><p>Language: en</p>",
language="en",
issn="0924-9338",
doi="10.1016/j.eurpsy.2007.04.001",
url="http://dx.doi.org/10.1016/j.eurpsy.2007.04.001"
}